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Abstract
Background: Label-retaining cells (LRCs) have been recognized as rare stem and progenitor-like cells, but their
complex biological features in renal repair at the cellular level have never been reported. This study was conducted
to evaluate whether LRCs in kidney are indeed renal stem/progenitor cells and to delineate their potential role in
kidney regeneration.
Methods: We utilized a long-term pulse chase of 5-bromo-2'-deoxyuridine (BrdU)-labeled cells in C57BL/6J mice to
identify renal LRCs. We tracked the precise morphological characteristics and locations of BrdU+LRCs by both
immunohistochemistry and immunofluorescence. To examine whether these BrdU+LRCs contribute to the repair of
acute kidney injury, we analyzed biological characteristics of BrdU+LRCs in mice after ischemia/reperfusion (I/R) injury.
Results: The findings revealed that the nuclei of BrdU+ LRCs exhibited different morphological characteristics in normal
adult kidneys, including nuclei in pairs or scattered, fragmented or intact, strongly or weakly positive. Only 24.3 ± 1.5 %
of BrdU+ LRCs co-expressed with Ki67 and 9.1 ± 1.4 % of BrdU+ LRCs were positive for TUNEL following renal I/R injury.
Interestingly, we found that newly regenerated cells formed a niche-like structure and LRCs in pairs tended to locate in
this structure, but the number of those LRCs was very low. We found a few scattered LRCs co-expressed Lotus
tetragonolobus agglutinin (LTA) in the early phase of injury, suggesting differentiation of those LRCs in mouse kidney.
Conclusions: Our findings suggest that LRCs are not a simple type of slow-cycling cells in adult kidneys, indicating a
limited role of these cells in the regeneration of I/R injured kidney. Thus, LRCs cannot reliably be considered stem/
progenitor cells in the regeneration of adult mouse kidney. When researchers use this technique to study the cellular
basis of renal repair, these complex features of renal LRCs and the purity of real stem cells among renal LRCs should be
considered.
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Background
Ischemia/reperfusion (I/R) is one of the leading causes
of acute kidney injury (AKI) [1]. Approximately two mil-
lion people die of AKI worldwide every year, despite the
widely available renal replacement therapies [2, 3]. Inter-
estingly, after acute injury, the kidney undergoes a quick
regeneration to recover from renal functional failure by
producing new cells. Thus, to develop targeted treatments
for AKI, a clear understanding of the cell type contribution
to the repair of injured kidney is a prerequisite. Whether
the cells responsible for kidney regeneration are terminally
differentiated tubular cells, pluripotent progenitor cells, or
adult renal stem cells is still controversial [4–8].
Adult stem cells contribute to tissue repair in many
organs such as skin, brain, heart, and gastrointestinal
mucosa [9–11]. Adult nephron progenitors have been
identified in zebrafish, but the role of adult stem/pro-
genitor-like cells in mammalian renal repair remains un-
clear [12, 13]. The evidence supporting the role of adult
stem/progenitor cells in the restoration of renal tubules
after ischemic injury is derived from the presence of renal
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label-retaining cells (LRCs) in adult rodents. In 2003, Mae-
shima et al. first demonstrated the existence of renal
progenitor-like tubular cells and their role in tubular re-
generation by a 2-week chase using the label-retaining cell
(LRC) technique [14]. Since then, the LRC technique has
been improved by a long chase period to search for stem/
progenitor cells in the adult mouse kidney. Using this tech-
nique, studies have been reported to demonstrate the role
of renal stem/progenitor cells in the regeneration of ische-
mic renal injury at specific locations, such as renal papilla
[15–17], S3 segment of proximal tubules [18], and the
junction of cortex and outer medulla [19]. However, based
on a lineage-tracing technique, recent studies showed that
the surviving native tubular epithelial cells repaired the
injured kidney without involving specialized progenitors
[7, 20]. Thus, further studies are needed to resolve this
controversy and to judge the real existence of renal stem/
progenitor cells in the regeneration of adult kidney.
LRCs were recognized as rare stem and progenitor-
like cells based on their slow-cycling, quiescent nature
[21]. However, label retention by itself does not distin-
guish potential quiescent stem/progenitor cells from
other less proliferative cell types that are labeled during
the pulse period. Using the LRC technique in kidney,
different studies demonstrated varying localization and
function of LRCs during the repair of AKI [14–16, 18, 19,
22]. Rangarajan et al. revealed inconsistent localization of
LRCs in adult kidney following deoxyuridine treatment at
different dosages [23]. However, the complex biological
features of LRCs in renal repair have never been eluci-
dated. Considering the limitations of the LRC technique
[24], we sought to evaluate whether these LRCs in kidney
were indeed renal stem/progenitor cells and to delineate
their potential role in kidney regeneration.
Methods
BrdU labeling
Male C57BL/6J mice were purchased from Vital River
Laboratories (China). All animal procedures were given
approval by the animal ethics committee of Shandong
University (Jinan, China) and followed the Guide for the
Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No.
85–23, revised 1996). To investigate the long-term dis-
tribution of LRCs in mouse kidneys, postnatal mice were
injected intraperitoneally with 5-bromo-2'-deoxyuridine
(BrdU) (Sigma-Aldrich) at a dose of 50 μg/g twice daily,
starting from 12 hours after birth to 3 days [25, 26]. The
labeled pups were allowed to grow without a medical
operation until eight-weeks old.
Renal ischemia/reperfusion injury model
Eight-week-old BrdU-labeled C57BL/6J mice were sub-
jected to renal bilateral I/R injury. Each group contained
at least four mice. Briefly, mice were anesthetized with
chloral hydrate (125 mg/kg, intraperitoneally) [27], and
kidneys were exposed through a midline incision. The
renal artery and vein were isolated from surrounding tis-
sues and kidneys were subjected to ischemia by clamping
bilateral renal pedicles with non-traumatic mirovascular
clamps (Roboz Surg Instruments, USA) for 22 min [28,
29]. In the sham group, the renal pedicles were isolated
without using clamps. After removing the clamps, reper-
fusion was verified and the incision was sutured and 1 ml
of 37 °C saline was injected into the abdomen to supple-
ment fluid loss. Mouse body temperature was maintained
at 37 °C using a warming pad. Mice were sacrificed and
blood and tissue samples were collected at 1, 2, 3, 4, 5, 6,
9, 14, and 28 days after I/R injury.
Assessment of renal function
To assess renal function, serum creatinine (Scr) and
blood urea nitrogen (BUN) levels were monitored.
Serum was isolated from blood samples by centrifuga-
tion at 3000 rpm for 5 minutes. Scr and BUN were mea-
sured at the clinical laboratory of the Second Hospital of
Shandong University using an automatic biochemistry
analyzer (Beckman Instruments Inc., USA).
Histology and immunohistochemistry
Renal tissues were fixed in 4 % paraformaldehyde, dehy-
drated and embedded in paraffin, and 5-μm-thick sec-
tions were cut using a microtome. For general histology,
sections were stained with hematoxylin and eosin
(H&E). BrdU immunohistochemistry was performed to
determine the staining of LRCs [14, 25]. Primary anti-
bodies against BrdU (Merck Millipore, USA, 1:50) were
incubated with the sections overnight at 4 °C. Sections
were washed with PBS, incubated with biotinylated goat
anti-mouse IgG for 30 minutes, washed again and cov-
ered with horseradish peroxidase (HRP)-conjugated
streptavidin (Zymed laboratories, USA) for 30 minutes.
Next, a diaminobenzidine (DAB) solution was used to
obtain a visible brown staining. Staining of Ki67-positive
cells was performed in a similar manner. For the negative
control, the primary antibody was omitted to estimate the
specificity. Morphological images and examination of sec-
tions were captured by a light microscope (Nikon Instru-
ment Inc.).
Immunofluorescence
Renal tissues were embedded in OTC freezing medium
(Sakura Finetek, Torrance, CA, USA) and sliced into 5-
μm sections. The tissues were washed and blocked with
10 % goat serum for 30 minutes at room temperature,
incubated with both the mouse monoclonal anti-BrdU
(1:100) antibody and the rabbit polyclonal to Ki-67 antibody
(Abcam, Cambridge, UK;1:100) or Lotus tetragonolobus
Liu et al. Stem Cell Research & Therapy  (2016) 7:68 Page 2 of 13
agglutinin (LTA) antibody (Vector Labs, Berlingame, CA,
USA;1:200) overnight at 4 °C. After washing with PBS,
fluorescent secondary antibodies (rhodamine-conjugated
goat anti-mouse IgG and FITC-conjugated goat anti rabbit
IgG) were added to the sections in the dark for 1 hour
at room temperature, and 4’,6-diamidino-2-phenylindole
(DAPI) was used to stain nuclei. To observe cellular
death in kidney, terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) (FragEL™ DNA Frag-
mentation Detection Kit-Fluorescent, Merck, Germany)
was used by fluorescent staining the free 3' -OH termini
of DNA [30]. For negative controls, the primary antibody
was replaced with normal goat serum, which did not show
positive staining, thus confirming specificity. Pictures of
each section were obtained at × 200 or × 400 magnifica-
tion with a fluorescence microscope (ECLIPSE-TS100,
Nikon, Japan).
Quantification of BrdU or Ki 67 or TUNEL-positive cells
The quantification of BrdU-retaining cells was per-
formed by counting the number of positive nuclei in five
selected fields of sections in a blinded manner under a
light microscope at × 200. The average number was cal-
culated as the number of BrdU-retaining nuclei per field.
The fields of sections were generated from 3 ~ 4 sepa-
rated BrdU-labeled mice per group, and the quantitative
analysis was expressed by the average number of BrdU-
labeled cells in the five random fields [14, 25]. Quantification
of Ki 67 or TUNEL-positive cells was performed in a simi-
lar manner at × 400 magnification.
Statistical analysis
Data are presented as means ± SEM. Differences between
groups were analyzed by one-way ANOVA using SPSS
16.0. P < 0.05 was considered statistically significant.
Results
Restoration of mouse renal function and structure after
I/R injury
AKI activates pathways of cell death and cell prolifera-
tion. To investigate the natural healing process of in-
jured kidneys, we observed the renal functional and
structural changes in a mouse model of ischemic AKI.
Scr and BUN were measured as markers of renal function
Fig. 1 Restoration of renal function in C57BL/6J mice after I/R injury (n = 4 in each group). a Serum creatinine (Scr) level significantly increased
one day after injury and was restored to normal gradually over time. b The peak value of blood urea nitrogen (BUN) was found at the end of the
first day after injury, followed by return to normal levels (P < 0.05, I/R injured mice vs sham group). I/R ischemia/reperfusion
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at 0 (baseline), 1, 2, 3, 4, 5, 6, 9, 14, and 28 days after is-
chemia. We found significantly increased Scr levels on day
1. The peak value of Scr was 9-fold greater than the mean
baseline value (Scr in μmol/L, 1 day after injury vs base-
line, 175.93 ± 36.61 vs 19.53 ± 5.03, P < 0.05); it returned
to normal within 9 days (Fig. 1a). The trend of BUN after
I/R injury was consistent with Scr (Fig. 1b).
To verify and localize the renal injury and regeneration
directly, we examined the histological changes of kidney
tissues in ischemic AKI by H&E staining. Twenty-four
hours after I/R injury, we observed the typical renal
tubular damage, such as severe tubular dilatation, loss of
brush border, sloughed debris in tubular lumen space,
and denuded basement membrane. The typical renal
tubular damage lasted 3 days in renal cortex, medulla,
and papilla (Fig. 2). On day 4, the newly generated tubu-
lar cells increased rapidly and formed a special niche-
like structure of new cells (arrows in Fig. 2 and Fig. 3).
The renal structure tended to restore rapidly within the
next 3 ~ 5 days. Nine days after I/R injury, kidney tissues
clearly showed normal histological architecture of renal
cortex, medulla, and papilla (Fig. 2). These results indi-
cated that the adult mouse kidney manifested natural re-
generative capacity to repair I/R injured tubular cells.
Fig. 2 Renal histology in I/R injury. Kidney tissues from C57BL/6J mice with 22 min of bilateral renal ischemia or sham operation were collected
on 1, 2, 3, 4, 5, 6, 9, 14, and 28 days and stained with H&E for histological examination. During the first 3 days of injury, kidney tissues showed
severe tubular dilatation, loss of brush border, and sloughed debris in tubular lumen space. On day 4, the newly generated tubular cells increased
rapidly. Nine days after I/R injury, the structure of damaged tissues showed normal histological architecture in cortex, medulla, and papilla
(arrows, on day 4 and 6, indicate the special niche-like structure of newly restored tubular cells; magnification × 400). I/R ischemia/reperfusion,
H&E hematoxylin and eosin
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Distribution and morphological characteristics of
long-term LRCs in normal mouse kidneys
To investigate the nature and potential role of long-term
LRCs further, we first identified the precise location of
these cells in normal adult mouse kidneys. After an 8-
week chase period with BrdU, we found that BrdU+
LRCs scattered among adult kidneys (Fig. 4 and Fig. 5).
The difference in the number of these cells in cortex,
medulla, and papilla was statistically significant (Fig. 3b
P < 0.05). Most BrdU+ LRCs were located on the tubular
cells, with a few scattered on renal interstitium (Fig. 5).
These results indicated that the adult mouse kidney
retained original cells that were quiescent in DNA syn-
thesis within the first 3 days after birth.
In addition, to study the morphological characteristics
of these cells directly, we observed BrdU+ LRCs under a
microscope immunohistochemically. A few of the BrdU+
LRCs were located in pairs, and the number of these
cells in total BrdU+ LRCs was 21.7 ± 1.5 % (Fig. 5 solid
arrows, d). We observed that the nuclei of long-term
BrdU+ LRCs exhibited different morphological charac-
teristics in normal adult kidneys. Some of their nuclei
were fragmented and disassembled, in approximately
10.1 ± 0.9 % of the BrdU+ LRCs (Fig. 5 dotted arrows, d).
These fragmented and disassembled nuclei showed the
variation of long-term LRCs in adult mouse kidneys,
suggesting DNA damage or defect in these LRCs. In
addition to slow-cycling cells, the damaged and non-
proliferating cells may also be labeled by long-term
BrdU+ LRCs in adult mouse kidney.
Limited role of long-term LRCs in the regeneration of I/R
injured kidney
Eight weeks after BrdU-labeled mice underwent the
renal I/R injury, we observed that the distribution of
BrdU+ LRCs diminished over time with renal functional
recovery. In the first 3 days after injury, the number of
BrdU+ LRCs in medulla and papilla dramatically de-
creased while the majority of these cells in cortex de-
creased 4 days after injury (Fig. 6). For the repair process
Fig. 3 The newly regenerated cells formed a niche-like structure on day 4 during the repair process of I/R injury. a Kidney tissues stained with
H&E for histological examination by magnification × 200; b Ki67-positive cells in medulla and papilla by immunohistochemistry (magnification × 400);
c Ki67-positive cells in medulla and papilla by immunofluorescence (magnification × 400). I/R ischemia/reperfusion, H&E hematoxylin and eosin
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of acute renal I/R injury, both cell death and prolifera-
tion are essential components in the remodeling of tis-
sue structures [31]. Thus, to investigate the contribution
of LRCs in renal tubule regeneration after I/R injury, we
first stained newly proliferating cells with Ki67, which
specifically recognizes the proliferating cells [32], and
stained apoptotic cells by TUNEL kit in our murine
model. TUNEL+ cells peaked at 2 days after ischemic
injury and a number of Ki67+cells were observed
among tubular cells in ischemic kidneys 24 h after re-
perfusion (Fig. 7). At 4 days after the initial injury, Ki67
+cells were significantly increased. Quantitative analysis
of the number of TUNEL+ cells or Ki-67+ cells is shown
in Fig. 7. These results indicated that apoptosis of tubu-
lar cells peaked at 2 days after ischemic injury, which is
followed by a well-established repair phase of tubule re-
generation via proliferation of tubular cells 3 ~ 5 days
after injury. Therefore, we speculated that the quick
disappearance of LRCs in the first 4 days after I/R in-
jury may be due to both ablation of superfluous apop-
totic cells and newly proliferating cells in the process of
remodeling injured renal structures.
To verify this speculation, we further stained the co-
localization of long-term LRCs and Ki-67+cells or
Fig. 4 Localization of BrdU-retaining cells in 8-week-old mouse kidneys using immunofluorescence. a BrdU+ LRCs (red) scattered among normal
adult kidneys; b BrdU-retaining cells in cortex, medulla, and papilla. BrdU-retaining cells were quantified by counting the number of positive
nuclei in five randomly selected fields of sections under a fluorescence microscope (magnification × 200). BrdU 5-bromo-2'-deoxyuridine,
LRCs label-retaining cells
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TUNEL+cells in murine kidney after renal ischemia. On
day 4, a period of renal recovery with more tubule pro-
liferation and fewer cell deaths, we observed that not all
BrdU+ LRCs were positive for Ki67 (Fig. 8a). BrdU+Ki67
+ cells constituted only 24.3 ± 1.5 % of the total BrdU+
LRCs, and the majority of these BrdU+ LRCs occurred
in pairs (arrows in Fig. 8a). BrdU+ LRCs located in pairs
tended to distribute in the niche-like structure formed
by newly proliferating cells. These results indicated
that only a few of the total BrdU+ LRCs re-entered the
cell cycle to contribute to the regeneration of I/R in-
jured kidneys. In addition, we found that 9.1 ± 1.4 % of
BrdU+LRCs co-expressed with TUNEL at day 4 after
injury, and TUNEL+BrdU+cells were observed in iso-
lated scattered BrdU+LRCs (arrows in Fig. 8b). This re-
sult demonstrated that long-term LRCs included cells
with DNA fragmentation in the mouse kidney after in-
jury and further indicated that not all the LRCs played
a positive role in the regeneration process of I/R in-
jured kidney.
Phenotype of long-term LRCs in mouse kidney after I/R
injury
To further characterize the differentiation of LRCs, we ex-
amined the expression of Lotus tetragonolobus agglutinin
(LTA), a marker of proximal tubular cell differentiation, in
controls and I/R injured renal tissues. We found that
some isolated scattered BrdU+ LRCs co-expressed LTA
both in normal and I/R injured kidney, demonstrating that
a few LRCs were in a differentiated state in the early phase
of renal injury (arrowheads in Fig. 9). These results
indicated that the scattered LRCs might not be the real
stem-cell pool, and the regenerated immature cells might
not be derived from long-term renal LRCs completely.
Interestingly, BrdU+LRCs located in pairs did not co-
express LTA in mouse kidney after I/R injury (arrows
in Fig. 9). With the serious damage of I/R injured kid-
ney on day 2, BrdU+LRCs seldom co-expressed LTA,
indicating dedifferentiation of these LRCs at time
points after I/R injury or migration of LRCs in kidney.
Discussion
In this study, we demonstrated that the adult mouse kid-
ney was capable of spontaneously restoring its functions
from I/R injury, with only a small part of the total long-
term BrdU+LRCs contributing to this regeneration.
During the process, we found a few scattered LRCs exhi-
biting the characteristics of apoptotic cell death and cell
differentiation in the early phase of tubular damage,
which is inconsistent with the properties of stem/pro-
genitor-like cells. Additionally, we first observed that
the nuclei of long-term BrdU+ LRCs exhibited different
morphological characteristics in normal adult kidneys,
including fragmentation and disassembly of nuclei. Al-
though we cannot rule out that LRCs in pairs are the
real stem/progenitor cells in mouse kidney, we demon-
strated that not all long-term LRCs represent the real
niche of stem/progenitor cells in adult kidneys. Thus,
our novel findings can serve as a reminder that putative
renal stem/progenitor cell niches identified by the LRC
technique in previous studies, such as renal papillae,
need to be re-evaluated.
Fig. 5 Localization of BrdU-retaining cells by staining with the DAB lectin in 8-week-old mouse kidneys. a In the cortex, most of the
BrdU-retaining cells were located among the tubular cells, and a few of them were scattered in renal interstitium; b Localization of
BrdU-retaining cells in the medulla; c BrdU-retaining cells on the renal papilla; d Quantitative analysis of BrdU+ LRCs located in pairs
(solid arrows) and BrdU+ LRCs revealed nuclear fragmentation and disassembly (dotted arrows, magnification × 400). BrdU 5-bromo-2'-deoxyuridine,
DAB diaminobenzidine, LRCs label-retaining cells
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Although label-retaining cells have been observed in
adult rodent kidney since 2003, the exact localization
and the number of those cells are still controversial [23].
In the present study, we found that the number of long-
term BrdU+ LRCs in cortex or medulla is much higher
than that in papilla of 8-week old male C57BL/6J mice
(Figs. 4 and 6). However, Rangarajan et al. showed a
lower number of neonatal LRCs located in cortex or
medulla and a higher number in the papilla [23]. One of
the possible reasons for this discrepancy is mainly due
to the sex differences in mouse between the studies.
Rangarajan et al. used female C57BL/6J mice, while we
used male mice for the present study. As we know, sex
difference is found in responses to ischemia/reperfusion-
induced acute kidney injury and females may attenuate
the kidney injury [33–36]. In our study, the distribution
of long-term LRCs also showed sex differences in the
differing compartments of murine kidney compared with
Rangarajan et al.’s study. Given that long-term LRCs
were identified as somatic stem/progenitor-like cells, di-
verse distributions of those cells between different gen-
ders may be one potential explanation for the greater
susceptibility to I/R renal injury in the male gender.
Additionally, differences in methods of labeling adminis-
tration, time interval of injection, species, and labeling
markers may also result in inconsistent localization of
LRCs between each of these studies [14, 17, 37]. For ex-
ample, Oliver et al. labeled long-term LRCs by giving
BrdU subcutaneously to 3-day-old Sprague-Dawley rats,
while we labeled LRCs intraperitoneally, as in most stud-
ies on neonatal mice, twice daily from 12 hours after
birth to 3 days. Renal tissue in neonatal rodent under-
goes active development every day, especially within 7
days after birth [38, 39]. So the timing and methods of
administration of deoxyuridine in rodent have an im-
portant effect on the localization of LRCs. In short, the
above differences that exist in different studies should be
considered when researchers estimate the localization of
LRCs in adult kidney.
Among our results was the novel finding of the vari-
ation of long-term LRCs in adult mouse kidneys which
was directly observed by a microscope immunohisto-
chemically. Our results showed that the nuclei of long-
term BrdU+LRCs were in pairs or scattered, fragmented
or intact, strongly or weakly positive (Fig. 5), indicating
different classes of long-term LRCs in adult mouse kidney.
Thus, we observed biological characteristics of these LRCs
in responses to I/R injury to clarify their roles in adult kid-
ney. Although previous studies had observed that LRCs
contributed to renal repair, the exact percentage of those
LRCs counted by statistical analysis or the complex char-
acteristics of long-term LRCs in the regeneration period
of adult mouse kidney after I/R injury has never been re-
ported [14, 15, 17, 19, 22]. In our study, we found that
only 24.3 ± 1.5 % of total BrdU+LRCs co-expressed with
Ki67 and 9.1 ± 1.4 % of BrdU+LRCs were positive for
TUNEL at day 4 after injury (Fig. 8). Results showed newly
regenerated cells did not completely derive from renal
long-term LRCs in adult mouse kidneys. These results also
showed only a small part of LRCs were responsible for re-
pair, and most of the re-cycle LRCs were in pairs (Fig. 8a).
Long-term LRCs exhibited complex characteristics,
Fig. 6 BrdU-retaining cells in mouse kidneys after I/R injury. After an
8-week chase period, the BrdU-labeled C57BL/6J mice were subjected
to renal bilateral I/R injury. Kidney tissues were harvested 1, 2, 3, 4, 5, 6,
9, 14, and 28 days after I/R injury. BrdU-retaining cells were stained a
visible brown color without using the hematoxylin. a Quantification of
BrdU-retaining cells in I/R injured kidneys from the cortex, medulla, and
papilla; LRCs diminished over time with renal functional recovery; four
days after injury, the number of LRCs decreased dramatically. b Kidney
sections from BrdU-stained cortex, medulla, and papilla showed the
disappearance of LRCs after I/R injury. Upon restoration and recovery
of the structure of the I/R injured kidney to normal within 1 month,
LRCs were difficult to detect (magnification × 200). BrdU 5-bromo-2'-
deoxyuridine, I/R ischemia/reperfusion, LRCs label-retaining cells
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including cell proliferation, apoptosis and others that are
unknown. Indeed, most of the BrdU+LRCs did not reenter
the cell cycle after injury. Therefore, the proportion of
long-term LRCs which can represent true stem/progenitor
cells in the I/R injured kidney is also very low, consistent
with the finding observed in the hematopoietic system [24].
Further studies will be needed to test the differentiation po-
tency of these LRCs by isolated culture or biological
markers to redefine these cells.
The majority of published studies about LRCs in renal
repair did not report the severity of renal injury by mon-
itoring renal function or structure in their animal
models of ischemic AKI. Given that different severity of
renal injury affects the spontaneous remodeling process
in adult kidney [18, 29], we estimated both renal func-
tion and histological changes and analyzed both prolifer-
ating cells and apoptotic cells in our murine model.
Results showed apoptosis of tubular cells peaked at 2
Fig. 7 Analysis of the expression of Ki67-positive cells (a, c) and TUNEL-positive cells (b, d) in mouse kidneys after IRI (magnification × 400)
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days after ischemic injury, which is followed by a repair
phase of tubule proliferation that peeked on the 4th day
(Fig. 7). During the process, the number of LRCs
decreased with the repair process of I/R injured kidney,
especially during the first 4 days after injury (Fig. 6). The
causes of the loss of long-term LRCs after injury are still
controversial. Oliver et al. attributed this phenomenon
to reentry of LRCs into the cell cycle during the repair
phase [15], whereas Humphreys et al. recently showed
that cell division could not explain the loss of LRCs [7,
15]. We speculated that ablation of superfluous apop-
totic cells may be one of the reasons for the quick dis-
appearance of LRCs in the first 4 days after I/R injury.
Interestingly, we found that newly regenerated cells
formed a niche-like structure (Fig. 3), and LRCs in pairs
tended to locate in this structure (Fig. 8a). Most isolated
scattered BrdU+ LRCs did not co-express Ki67 in the
renal repair process. In this study, we also observed that
a terminal differentiated proximal tubule marker, LAT,
co-expressed in scattered BrdU+ LRCs in the early phase
of renal injury (Fig. 9). This result further revealed the
characteristic differentiation of a few long-term LRCs.
Previous studies explained these differentiated LRCs as
transit–amplifying (TA) cells, which are the early de-
scendants of stem cells [14]. In our study, these differen-
tiated LRCs were observed before the proliferating peak.
Thus, these LRCs cannot be considered as TA cells.
The LRC technique is based on the assumption that
somatic stem cells are quiescent or retain their original
template DNA strands as they undergo slow cell cycle,
compared with the majority of cells in the tissue. Al-
though this technique has been used to identify stem
cells in the mammary gland [40], neural stem cells [41]
and the skin [42], it has its own limitations. On the one
hand, stem cells in tissues cannot be completely detected
by LRCs, challenging the recognition and quantification
of stem cells using this method [43, 44]. On the other
hand, not all LRCs are recognized as stem/progenitor
cells. For example, Kiel et al. reported that fewer than
0.5 % of LRCs in the hematopoietic system are stem cells
[24]. Another study showed that other long-lived, rarely
cycling cells, such as leukocytes and endothelial cells,
may be identified as LRCs [21]. Thus, label retention is
neither sensitive nor specific for identifying stem/pro-
genitor cells. Further, in our study, immunofluorescence
showed that 9.1 ± 1.4 % of BrdU+ LRCs co-expressed cel-
lular apoptosis marker in adult kidneys after the I/R in-
jury (Fig. 8b). Immunohistochemical analysis revealed
fragmentation and disassembly of 10.1 ± 0.9 % of the nu-
clei (Fig. 5). Therefore, we speculated that those LRCs
may be arrested in the early phase of the cell cycle as a
consequence of DNA damage or defect. The damaged
and non-proliferating cells were also labeled, showing
prolonged BrdU retention. Thus, our results further
demonstrate that LRCs are not simple slow-cycling cells
in adult kidneys, including cells with DNA damage or
defect in the early phase.
Fig. 8 Contribution of BrdU+ LRCs in the regeneration of I/R injured
mouse kidneys. a Double-immunofluorescence staining for BrdU
(red) and Ki67 (green) to visualize the role of BrdU+ LRCs in cell
proliferation 4 days after IRI. Newly generated cells formed a special
niche-like structure (green), and only some of the BrdU+ LRCs
co-expressed Ki-67 in this area (arrows). b Double immunofluorescence
was used to determine BrdU+ LRCs undergoing cellular apoptosis
on day 4. Scattered BrdU+ LRCs co-expressed TUNEL (arrows)
(arrows indicate the double-stained location; magnification × 400).
BrdU 5-bromo-2'-deoxyuridine, LRCs label-retaining cells,
I/R ischemia/reperfusion
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Renal papilla is the structure composed of collecting
ducts, loops of Henle, vasculature, and interstitial stro-
mal cells [26]. Previous studies reported that LRCs of
the renal papilla play a role in repair after ischemic
injury and papillary LRCs were regarded as a stem cell
niche in adult kidney [15–17, 45]. Recently, these
findings have been questioned by using the genetic
lineage analysis in kidneys [46]. Humphreys et al. have
demonstrated that papillary LRCs do not contribute to
the repair of I/R injured tubular cells. We also observed
the papillary LRCs in our study, and our findings about
complex biological characteristics of LRCs may provide
a rational explanation for the inconsistent results.
The reason for the manifestation of different biological
features by renal LRCs in the regeneration of I/R injured
mice is also an unresolved issue. We speculate that since
BrdU was injected over a 3.5-day period, characteristics
of BrdU+LRCs might be varied during the active renal
development in the first 7 days after birth. Renal LRCs
may also include cells that are arrested in the early phase
of the cell cycle as a consequence of DNA damage or
defect. A recent study presented similar findings, sug-
gesting that renal LRCs were not the same population
with respect to different loading and chase periods [23].
In summary, we report novel findings that long-term
renal LRCs exhibited multiple biological characteristics
during the recovery from I/R injury in mouse kidneys.
Renal LRCs do not totally represent the adult stem-cell
population based on our observations of apoptotic LRCs
and terminally differentiated LRCs in mouse kidneys. Al-
though we cannot rule out the possibility that a small
number of LRCs located in a special structure formed by
newly proliferating cells in pairs are genuine stem pro-
genitor cells, our findings demonstrate that long-term
LRCs are not uniform in adult kidneys. This diversity in
the LRC population should be considered in studies
searching for real stem/progenitor cells in adult kidneys
by the LRC technique. The purity of real stem cells among
LRCs should be assessed in studies exploring the cellular
basis of renal repair using this technique. Furthermore,
Fig. 9 BrdU+ LRCs (red) co-expressed LTA (green) both in normal and I/R injured kidney (The arrows indicate LRCs in pairs, the arrowheads
indicate isolated LRCs; magnification × 400). BrdU 5-bromo-2'-deoxyuridine, LRCs label-retaining cells, LTA Lotus tetragonolobus agglutinin,
I/R ischemia/reperfusion
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our results also show that adult kidneys exhibit spontan-
eous recovery from acute renal injuries. Therefore, further
studies are needed to clarify the types of renal cells medi-
ating the repair and the remodeling of acutely injured kid-
neys to develop targeted interventions.
Conclusions
Overall, this study revealed that long-term LRCs were
not simple slow-cycling cells in adult kidneys, including
cells with DNA damage or terminal differentiation in
both normal and early I/R injury phase. Newly regener-
ated cells formed a niche-like structure to spontaneously
repair injured renal cells, while only a small part of the
LRCs in pairs tended to locate in this structure. Most
isolated scattered LRCs did not reenter the cell cycle
after injury, suggesting a limited role of long-term LRCs
in the regeneration of I/R injured kidney. Thus, when re-
searchers use the LRC technique to locate true stem/
progenitor cells and to study the cellular basis of renal
repair, these complex features of renal LRCs and the
purity of real stem cells among renal LRCs should be
considered.
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